|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Stem Cells | ||||||||||||||||
| May 23, 2003 | ||||||||||||||||
|
marcus evans Life Sciences, London, England 24-25 September 2003 Key Topics * Actual market consolidation * Funding, partnering and collaboration * Progress for clinical applications of adult and embryonic stem cells in therapeutic areas * Alternative uses for stem cells * Impact of regulatory issues world-wide |
||||||||||||||||
| Organized by: | marcus evans Life Sciences | |||||||||||||||
| Invited Speakers: | John Sinden, Chief Scientific Officer, RENEURON. Annemarie Moseley, Acting Chief Executive Officer, LAYTON BIOSCIENCES INC.. Jane Lebkowski, Vice President, Research and Development, Regenerative Medicine, GERON CORPORATION. Darwin Prockop, Director, Center for Gene Therapy, TULANE UNIVERSITY. Denise Pollard-Knight, Head of Healthcare Private Equity, NOMURA INTERNATIONAL. Linsong Li, Professor and Director, PEKING UNIVERSITY STEM CELL RESEARCH CENTER. Ping Wu, Assistant Professor, Department of Anatomy and Neurosciences, UNIVERSITY OF TEXAS MEDICAL BRANCH. Dianna DeVore, Chief Operating Officer , NATIONAL STEM CELL CENTRE, AUSTRALIA. Line Matthiessen, Principal Scientific Officer, Directorate E, "Biotechnology, Agriculture and Food" Unit "Strategic and Policy Aspects", EUROPEAN COMMISSION, DG RESEARCH. + more |
|||||||||||||||
| Deadline for Abstracts: | n/a | |||||||||||||||
| Registration: | ||||||||||||||||
| E-mail: | olas@marcusevansuk.com | |||||||||||||||
| Posted by: | Ola Samuelsson | |||||||||||||||
| Host: | 194.74.216.2 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||